The Cancer News Daily
The latest in cancer medicine and translational research by Wafik El-Deiry MDPhD
The latest in cancer medicine and translational research by Wafik El-Deiry MDPhD
Key Points. The inherited AnWj-negative blood group phenotype is caused by homozygosity for a deletion in MAL, encoding Myelin and lymphocyte proteinMal pr
Wafik El-Deiry: Thanks to Sendurai Mani for organizing the 2nd Annual Translational Oncology Symposium / Brown University, cancer, Cancer research, medical
The potential market for the Novartis drug Kisqali could grow markedly, now that certain early-stage breast cancer patients will be able to receive it.
Restoration of the p53 pathway has been a long-term goal in the field of cancer research to treat tumors with mutated p53 and aggressive clinical…
Tumor-infiltrating lymphocyte, or TIL, therapy is the first T cell treatment for solid tumors. It fights melanoma and maybe other cancers too.
‘Technology guides discovery but ideas drive technology’
Lin et al. perform multimodal genome-wide CRISPR knockout screens in primary CD8 T cells for genes controlling fitness upon differential stimulation. They identify Dap5, Icam1, and Ctbp1,…
PHILADELPHIA, September 13, 2024 – Following her transformative tenure at the American Cancer Society (ACS) and its advocacy affiliate the American Cancer Society Cancer Action…
For years, but especially since the pandemic, this page and many others in Science and elsewhere have been filled with lamentations about the spread of…
TEX264, a conserved and cancer-relevant autophagy receptor, orchestrates selective autophagy of DNA lesions induced by topoisomerase 1 cleavage complexes to ensure genome stability and cell…